AG真人官方

UBS AG is offering Contingent Income Auto-Callable Securities linked to the common stock of PayPal Holdings, Inc. (PYPL). The notes are senior unsecured obligations of UBS AG London Branch, priced at $1,000 per security, with expected issuance on 16 July 2025 and maturity on or about 14 July 2028 (鈮�36 months).

Coupon mechanics: investors receive a fixed contingent payment of $27.875 per quarter (鈮�11.15 % p.a.) for any determination date on which PYPL鈥檚 closing price is at least 65 % of the initial price (鈥渄ownside threshold鈥�). If, on any determination date other than the final one, PYPL closes at or above 100 % of the initial price (鈥渃all threshold鈥�), the notes are automatically redeemed for $1,000 + the current coupon.

Principal repayment: 鈥� If the final price on 11 July 2028 is 鈮�65 % of the initial price, holders receive principal plus the final coupon. 鈥� If it is <65 %, UBS will pay a cash value equal to the percentage decline in PYPL, exposing investors to a 1-for-1 loss below the threshold and up to 100 % loss of principal. There is no upside participation in PYPL shares.

Key economics & costs: 鈥� Estimated initial value: $937.30 鈥� $967.30 (3.3 %-6.3 % below issue price), reflecting dealer margins, hedging and funding costs. 鈥� Up-front fees total 2.25 % of principal (1.75 % sales commission, 0.50 % structuring fee). 鈥� Securities will not be listed; UBS Securities LLC intends, but is not obligated, to provide a secondary market.

Risk highlights: investors face (i) issuer credit risk of UBS AG, (ii) equity risk in PYPL, (iii) liquidity risk given the unlisted nature, (iv) early-call reinvestment risk, and (v) tax uncertainty; the notes are treated as prepaid derivatives with ordinary-income coupons.

Investor profile: suitable only for sophisticated investors who can tolerate loss of principal, limited upside, and illiquidity in exchange for above-market contingent income.

Form 8-K Highlights: Hyperion DeFi, Inc. (formerly Eyenovia, Inc.) filed a current report covering two principal matters: (1) departure of its Chief Operating Officer and (2) a corporate name and ticker change.

Executive departure (Item 5.02): Effective July 1, 2025, COO Bren Kern鈥檚 employment terminated in connection with a previously announced reduction-in-force. Under a Separation and Release Agreement, he will receive 12 months of base salary and up to 12 months of continued health-care benefits, conditioned upon standard release and covenant provisions. The agreement is attached as Exhibit 10.1.

Name and ticker change (Item 5.03): A Certificate of Amendment filed June 30, 2025, changed the company鈥檚 legal name from Eyenovia, Inc. to Hyperion DeFi, Inc., effective 8:00 a.m. ET on July 1, 2025. Board approval under Delaware General Corporation Law 搂242 was sufficient; no stockholder vote was required. Common shares retain the same rights and CUSIP, but the Nasdaq ticker will convert from 鈥淓YEN鈥� to 鈥淗YPD鈥� beginning July 3, 2025.

Reg FD disclosure (Item 7.01): A press release regarding the rebrand and ticker change was furnished (Exhibit 99.1) and is not deemed 鈥渇iled鈥� for Exchange Act liability.

Exhibits:

• 3.1 鈥� Certificate of Amendment (Name Change)
• 10.1 鈥� Separation and Release Agreement (COO)
• 99.1 鈥� Press Release announcing changes
• 104 鈥� Inline XBRL cover page

The filing is primarily administrative; it signals a strategic rebranding without altering share structure, while simultaneously disclosing senior management turnover that may raise continuity concerns.